Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study

Stephan Stilgenbauer, Francesc Bosch, Osman Ilhan, Jens Kisro, Béatrice Mahé, Eva Mikuskova, Dzhelil Osmanov, Gianluigi Reda, Sue Robinson, Eugen Tausch, Mehmet Turgut, Marcin Wójtowicz, Sebastian Böttcher, Thomas Perretti, Peter Trask, Marlies Van Hoef, Véronique Leblond, Robin Foà

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study'. Together they form a unique fingerprint.

Medicine & Life Sciences